Melanoma Combo Treatment May Work For Other Cancers
11/19/2012
Two kinds of cancer treatments are being trialed in combination for the first time on melanoma patients, according researchers from the Medical Oncology Skin and Melanoma Clinical Service at Peter MacCullum Cancer Centre, Australia. The researchers presented to delegates at the Clinical Oncological Society of Australia's Annual Scientific Meeting...
Different Approach Suggested After Progression In NSCLC Patients
11/19/2012
Right now, the best known treatment for patients with metastatic non-small cell lung cancer (NSCLC) with anaplastic lymphoma kinase gene rearrangements (ALK) or epidermal growth factor receptor mutations (EGFR) is crizotinib or EGFR tyrosine kinase inhibitors (TKIs), such as erlotinib, respectively. However, progression inevitably occurs...
Large-Scale Genomic Testing Feasible, Impacts Therapy According To Study
11/19/2012
Targeted cancer therapy has been transforming the care of patients with non-small-cell lung cancer (NSCLC). It is now standard practice for tumor specimens from NSCLC patients to be examined for EGFR mutations and ALK rearrangements to identify patients for therapy with EGFR and ALK inhibitors, respectively...
Treatment For Bone Metastases Can Improve Overall Survival
11/19/2012
It is common for patients initially diagnosed with lung cancer to have the cancer spread to sites like the liver, brain and bone. One of the most frequent sites of metastases is the bone, with an estimated 30 to 40 percent of patients with non-small-cell lung cancer (NSCLC) developing bone loss...
Structure Of Enzyme Unravelled Providing Basis For More Accurate Design Of Chemotherapeutic Drugs
11/19/2012
A group of researchers at the University of California, Berkeley have for the first time described the structure of the active site core of topoisomerase II alpha, an important target for anti-cancer drugs. The type II topoisomerases are important enzymes that are involved in maintaining the structure of DNA and chromosome segregation during both replication and transcription of DNA...
Skin Cancer Health Bill To Soar, Australia
11/19/2012
The cost of treating Australia's most common and expensive cancer will blow out to more than $700 million by 2015 as the population ages, according to a study published in the 19 November issue of the Medical Journal of Australia...
Study Shows Boost In Access To Breast And Cancer Screens
11/19/2012
A study by researchers at the George Washington University School of Public Health and Health Services (SPHHS) indicates that full implementation of the Affordable Care Act would expand health insurance coverage for more low-income women, enabling more than a million women to obtain potentially life-saving screening for breast and cervical cancer...
Discovery Of New Regulator Of The Blood Coagulation Cascade
11/19/2012
Researchers at the George Washington University School of Medicine and Health Sciences (SMHS) is featured as a top paper in the Journal of Biological Chemistry. Research by Rakesh Kumar, Ph.D...
Study Shows Boost In Access To Breast And Cancer Screens
11/19/2012
A study by researchers at the George Washington University School of Public Health and Health Services (SPHHS) indicates that full implementation of the Affordable Care Act would expand health insurance coverage for more low-income women, enabling more than a million women to obtain potentially life-saving screening for breast and cervical cancer...
Five Fall Foods That Protect Against Cancer
11/18/2012
There are an abundance of foods available this fall season that can help protect against cancer. Autumn is the best time to eat lots of fruits and vegetables because most of them are at their nutritional peak...